Cargando…

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors

BACKGROUND: Myelosuppression has been observed with several multikinase angiogenesis inhibitors in clinical studies, although the frequency and severity varies among the different agents. Inhibitors targeting vascular endothelial growth factor receptor (VEGFR) often inhibit other kinases, which may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, R, Crouthamel, M-C, Rominger, D H, Gontarek, R R, Tummino, P J, Levin, R A, King, A G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768111/ https://www.ncbi.nlm.nih.gov/pubmed/19844230 http://dx.doi.org/10.1038/sj.bjc.6605366

Ejemplares similares

Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease
por: Bluff, J E, et al.
Publicado: (2009)

Linoleic acid enhances angiogenesis through suppression of angiostatin induced by plasminogen activator inhibitor 1
por: Nishioka, N, et al.
Publicado: (2011)

Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines
por: Maddineni, S B, et al.
Publicado: (2005)

Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy
por: del Puerto-Nevado, L, et al.
Publicado: (2014)

Expression of IP-10 related to angiogenesis in uterine cervical cancers
por: Sato, E, et al.
Publicado: (2007)

Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction
por: Nagasaki, T, et al.
Publicado: (2014)

Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis
por: Rumjahn, S M, et al.
Publicado: (2009)

Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer
por: Siriwardena, B S M S, et al.
Publicado: (2006)

HOXC11–SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib
por: deBlacam, C, et al.
Publicado: (2011)

ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients
por: Lu, J, et al.
Publicado: (2013)

Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
por: Kumar, J, et al.
Publicado: (2014)

A role for nucleotides in support of breast cancer angiogenesis: heterologous receptor signalling
por: Yokdang, N, et al.
Publicado: (2011)

The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma
por: Pinato, D J, et al.
Publicado: (2013)

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy
por: Nieto, Y, et al.
Publicado: (2007)

Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation
por: van Miltenburg, M H A M, et al.
Publicado: (2014)

Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells
por: Kaistha, B P, et al.
Publicado: (2014)

Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis
por: Liu, W M, et al.
Publicado: (2012)

Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival
por: Ino, K, et al.
Publicado: (2006)

Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer
por: Kaneda, H, et al.
Publicado: (2011)

Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis
por: Srivastava, S K, et al.
Publicado: (2015)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)

The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension
por: Uschner, Frank Erhard, et al.
Publicado: (2018)

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response
por: Al-kaabi, M M, et al.
Publicado: (2015)

Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis
por: Osawa, T, et al.
Publicado: (2013)

Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis
por: De Smedt, L, et al.
Publicado: (2015)

Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer
por: Sasahira, T, et al.
Publicado: (2012)

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012)

Inhibition of constitutive and cxc-chemokine-induced NF-κB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells
por: Seaton, A, et al.
Publicado: (2009)

Breast cancer patients’ clinical outcome measures are associated with Src kinase family member expression
por: Elsberger, B, et al.
Publicado: (2010)

Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer
por: Wang, N, et al.
Publicado: (2014)

Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia
por: Maftouh, M, et al.
Publicado: (2014)

Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2α may signal skeletal muscle atrophy in weight-losing cancer patients
por: Eley, H L, et al.
Publicado: (2008)

Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers
por: Baruah, P, et al.
Publicado: (2015)

Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma
por: Keller, J, et al.
Publicado: (2013)

Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients
por: Jennings, C J, et al.
Publicado: (2015)

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis
por: Zheng, H-C, et al.
Publicado: (2006)

LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity
por: Morgan, R G, et al.
Publicado: (2018)

Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma
por: Tanaka, T, et al.
Publicado: (2014)

Platelet releasate promotes breast cancer growth and angiogenesis via VEGF–integrin cooperative signalling
por: Jiang, Lei, et al.
Publicado: (2017)

Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors
por: Farace, F, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8je7lfljvjak441m09jm00q8be